Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway.

Abstract

In liver resection and transplantation ischemia-reperfusion injury (IRI) is one of the main causes of organ dys- or nonfunction. The aim of the present study was to determine whether alpha-lipoic acid (LA) is able to attenuate IRI. Rat livers were perfused with Krebs-Henseleit buffer with or without LA (+/-wortmannin), followed by ischemia (1 h, 37 degrees C) and reperfusion (90 min). Efflux of lactate dehydrogenase (LDH) and purine nucleoside phosphorylase (PNP) and hepatic ATP content were determined enzymatically. Activation of NF-kappaB and activating protein 1 (AP-1) was examined by EMSA, and protein phosphorylation was examined by Western blot. Caspase-3-like activity served as an indicator for apoptotic processes. Animals treated intravenously with 500 micromol LA were subjected to 90 min of partial no-flow ischemia followed by reperfusion for up to 7 days. Preconditioning with LA significantly reduced LDH and PNP efflux during reperfusion in isolated perfused rat livers. ATP content was significantly increased in LA-treated livers. Postischemic activation of NF-kappaB and AP-1 was significantly reduced in LA-pretreated organs. Preconditioning with LA significantly enhanced Akt phosphorylation. It showed neither effect on endothelial nitric oxide synthase nor on Bad phosphorylation. Importantly, simultaneous administration of wortmannin, an inhibitor of the phosphatidylinositol (PI)3-kinase/Akt pathway, blocked the protective effect of LA on IRI, demonstrating a causal relationship between Akt activation and hepatoprotection by LA. Interestingly, despite activation of Akt, LA did not reduce postischemic apoptotic cell death. The efficacy of LA treatment in vivo was shown by reduced GST plasma levels and improved liver histology of animals pretreated with LA. This study shows for the first time that the PI3-kinase/Akt pathway plays a central protective role in IRI of the rat liver and that LA administration attenuates IRI via this pathway.

• Authors: Christian Müller, Friedrich Dünschede, Elke Koch, Angelika M Vollmar, Alexandra K Kiemer
• Journal: American journal of physiology. Gastrointestinal and liver physiology (Am J Physiol Gastrointest Liver Physiol) Vol. 285 Issue 4 Pg. G769-78 (Oct 2003) ISSN: 0193-1857 [Print] United States
• PMID: 12816756 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• NF-kappa B
• Proto-Oncogene Proteins
• Transcription Factor AP-1
• Thioctic Acid
• Adenosine Triphosphate
• L-Lactate Dehydrogenase
• Purine-Nucleoside Phosphorylase
• Akt1 protein, rat
• Protein Serine-Threonine Kinases
• Proto-Oncogene Proteins c-akt
• Mitogen-Activated Protein Kinases
• p38 Mitogen-Activated Protein Kinases
• Casp3 protein, rat
• Caspase 3
• Caspases

Topics

• Adenosine Triphosphate (analysis)
• Animals
• Caspase 3
• Caspases (metabolism)
• Enzyme Activation (drug effects)
• Ischemic Preconditioning (methods)
• L-Lactate Dehydrogenase (metabolism)
• Liver (blood supply, chemistry)
• Male
• Mitogen-Activated Protein Kinases (metabolism)
• NF-kappa B (metabolism)
• Phosphatidylinositol 3-Kinases (metabolism)
• Phosphorylation
• Protein Serine-Threonine Kinases
• Proto-Oncogene Proteins (metabolism)
• Proto-Oncogene Proteins c-akt
• Purine-Nucleoside Phosphorylase (metabolism)
• Rats
• Rats, Sprague-Dawley
• Reperfusion Injury (prevention & control)
• Thioctic Acid (administration & dosage)
• Transcription Factor AP-1 (metabolism)
• p38 Mitogen-Activated Protein Kinases